Deeg Mark Albert 4
4 · Regulus Therapeutics Inc. · Filed Jan 5, 2018
Insider Transaction Report
Form 4
Deeg Mark Albert
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-01-05+175,000→ 175,000 totalExercise: $1.24Exp: 2028-01-04→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]The option will vest in forty-eight equal monthly installments, such that the option will be fully vested four years from the date of grant, subject to the Reporting Person's continuous service to us.